Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylactic treatment of postperfusion bleeding using EACA.

A J DelRossi1, A C Cernaianu, S Botros

  • 1Department of Surgery, Cooper Hospital, Camden, NJ 08103.

Chest
|July 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atherogenesis and Lymphstasis...Connecting the Dots.

Lymphology·2018
Same author

Injury to the Temporal Lobe via Medial Transorbital Entry of a Toothbrush.

Journal of neurological surgery reports·2013
Same author

Giant aneurysms.

Neurosurgery·2001
Same author

BioGlue surgical adhesive for thoracic aortic repair during coagulopathy: efficacy and histopathology.

The Annals of thoracic surgery·2001
Same author

A novel technique in a sheep model for evaluating prosthetic heart valve performance.

Journal of investigative surgery : the official journal of the Academy of Surgical Research·2001
Same author

Hemangioma of the right ventricular outflow tract.

The Annals of thoracic surgery·2000
Same journal

Wearable-derived activity and physiological changes following pleural intervention in malignant pleural effusion.

Chest·2026
Same journal

The effect of a two-day stay at high altitude (2500 m) on right ventricular afterload and oxygen delivery in patients with pulmonary vascular disease A randomized controlled crossover trial.

Chest·2026
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
See all related articles

Prophylactic treatment with Epsilon-aminocaproic acid (EACA) significantly reduced blood loss and transfusion needs in patients undergoing open-heart surgery. This safe and tolerable approach also lowered the incidence of myocardial infarctions and reoperations for bleeding.

Area of Science:

  • Cardiovascular Surgery
  • Pharmacology

Background:

  • Postoperative bleeding is a significant complication after cardiopulmonary bypass surgery.
  • Minimizing blood loss and transfusion requirements is crucial for patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy and safety of prophylactic Epsilon-aminocaproic acid (EACA) in reducing blood loss post-cardiopulmonary bypass surgery.
  • To assess the impact of EACA on the incidence of myocardial infarctions, cerebrovascular accidents, and reoperations for bleeding.

Main Methods:

  • A randomized controlled trial involving 350 patients undergoing open-heart surgery.
  • EACA group received a loading dose followed by continuous intravenous infusion; control group received saline.
  • Chest tube blood loss, transfusion requirements, and adverse events were monitored for 24 hours postoperatively.

Related Experiment Videos

Main Results:

  • EACA-treated patients demonstrated significantly decreased chest tube blood loss at 24 hours.
  • Fewer myocardial infarctions, cerebrovascular accidents, and reoperations for bleeding were observed in the EACA group.
  • The EACA group required fewer units of blood transfusions compared to the control group.

Conclusions:

  • Prophylactic EACA administration is a safe and tolerable method to reduce total blood loss after open-heart surgery.
  • EACA treatment effectively decreases the need for blood transfusions and associated complications.
  • Epsilon-aminocaproic acid offers a beneficial adjunctive therapy in cardiopulmonary bypass procedures.